BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26040752)

  • 1. Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.
    Raza-Iqbal S; Tanaka T; Anai M; Inagaki T; Matsumura Y; Ikeda K; Taguchi A; Gonzalez FJ; Sakai J; Kodama T
    J Atheroscler Thromb; 2015 Aug; 22(8):754-72. PubMed ID: 26040752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression Profiles Induced by a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα) Pemafibrate.
    Sasaki Y; Raza-Iqbal S; Tanaka T; Murakami K; Anai M; Osawa T; Matsumura Y; Sakai J; Kodama T
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice.
    de la Rosa Rodriguez MA; Sugahara G; Hooiveld GJEJ; Ishida Y; Tateno C; Kersten S
    BMC Genomics; 2018 Jun; 19(1):443. PubMed ID: 29879903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.
    Takei K; Nakagawa Y; Wang Y; Han SI; Satoh A; Sekiya M; Matsuzaka T; Shimano H
    J Pharmacol Sci; 2017 Apr; 133(4):214-222. PubMed ID: 28366492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
    Dong T; Lyu J; Imachi H; Kobayashi T; Fukunaga K; Sato S; Ibata T; Yoshimoto T; Yonezaki K; Iwama H; Zhang G; Murao K
    Eur J Pharmacol; 2018 Nov; 838():78-84. PubMed ID: 30201376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Selective PPARα Modulator.
    Doi T
    J Atheroscler Thromb; 2015 Aug; 22(8):750-1. PubMed ID: 26250644
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective peroxisome proliferator-activated receptor α modulators (SPPARMα): the next generation of peroxisome proliferator-activated receptor α-agonists.
    Fruchart JC
    Cardiovasc Diabetol; 2013 May; 12():82. PubMed ID: 23721199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
    Araki M; Nakagawa Y; Oishi A; Han SI; Wang Y; Kumagai K; Ohno H; Mizunoe Y; Iwasaki H; Sekiya M; Matsuzaka T; Shimano H
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma mannose-binding lectin is stimulated by PPARα in humans.
    Rakhshandehroo M; Stienstra R; de Wit NJ; Bragt MC; Haluzik M; Mensink RP; Müller M; Kersten S
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E595-602. PubMed ID: 22215653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.
    Sairyo M; Kobayashi T; Masuda D; Kanno K; Zhu Y; Okada T; Koseki M; Ohama T; Nishida M; Sakata Y; Yamashita S
    J Atheroscler Thromb; 2018 Feb; 25(2):142-152. PubMed ID: 28781340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial.
    Ishibashi S; Yamashita S; Arai H; Araki E; Yokote K; Suganami H; Fruchart JC; Kodama T;
    Atherosclerosis; 2016 Jun; 249():36-43. PubMed ID: 27062408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α.
    Tateno C; Yamamoto T; Utoh R; Yamasaki C; Ishida Y; Myoken Y; Oofusa K; Okada M; Tsutsui N; Yoshizato K
    Toxicol Pathol; 2015 Feb; 43(2):233-48. PubMed ID: 25107573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of Molecular Mechanism of a Selective PPARα Modulator, Pemafibrate, through Combinational Approaches of X-ray Crystallography, Thermodynamic Analysis, and First-Principle Calculations.
    Kawasaki M; Kambe A; Yamamoto Y; Arulmozhiraja S; Ito S; Nakagawa Y; Tokiwa H; Nakano S; Shimano H
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes.
    Cornu-Chagnon MC; Dupont H; Edgar A
    Fundam Appl Toxicol; 1995 Jun; 26(1):63-74. PubMed ID: 7657063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
    Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
    Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.
    Rakhshandehroo M; Hooiveld G; Müller M; Kersten S
    PLoS One; 2009 Aug; 4(8):e6796. PubMed ID: 19710929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.